Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 14/20 | 0.81 |
| ▸ | CTSD | P07339 | 2/20 | 0.81 |
| ▸ | UGT1A1 | P22309 | 4/20 | 0.50 |
| ▸ | ABCB11 | O95342 | 3/20 | 0.50 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.50 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.50 |
| ▸ | MLNR | O43193 | 2/20 | 0.50 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.50 |
| ▸ | SLCO2B1 | O94956 | 2/20 | 0.50 |
| ▸ | CCKAR | P32238 | 2/20 | 0.50 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.50 |
| ▸ | GHSR | Q92847 | 2/20 | 0.50 |
| ▸ | SLCO1B3 | Q9NPD5 | 2/20 | 0.50 |
| ▸ | SLCO1B1 | Q9Y6L6 | 2/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.41 |
| ▸ | ABCC3 | O15438 | 2/20 | 0.41 |
| ▸ | ABCC4 | O15439 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3098371 | 1.00 | CYP3A4 (0.81) | CYP3A4CTSDUGT1A1ABCB11ABCB1 | |
| SCHEMBL3802684 | 0.95 | CYP3A4 (0.73) | CYP3A4CTSDUGT1A1ABCB11ABCB1 | |
| SCHEMBL3800663 | 0.95 | CYP3A4 (0.73) | CYP3A4CTSDUGT1A1ABCB11ABCB1 | |
| SCHEMBL3800673 | 0.95 | CYP3A4 (0.73) | CYP3A4CTSDUGT1A1ABCB11ABCB1 | |
| SCHEMBL3095203 | 0.93 | CYP3A4 (0.83) | CYP3A4CTSDUGT1A1ABCB11ABCB1 | |
| SCHEMBL3100620 | 0.93 | CYP3A4 (0.83) | CYP3A4CTSDUGT1A1ABCB11ABCB1 | |
| SCHEMBL3097946 | 0.92 | CYP3A4 (0.69) | CYP3A4CTSDUGT1A1ABCB11ABCB1 | |
| SCHEMBL3097185 | 0.91 | CYP3A4 (0.92) | CYP3A4CTSDUGT1A1ABCB11ABCB1 | |
| SCHEMBL3098594 | 0.90 | CYP3A4 (0.78) | CYP3A4CTSDUGT1A1ABCB11ABCB1 | |
| SCHEMBL3100142 | 0.90 | CYP3A4 (0.78) | CYP3A4CTSDUGT1A1ABCB11ABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2266971-A2 | Hiv protease inhibiting compounds | Abbott Laboratories (US) | 2010-12-29 | — | — | EP | claimed |
| US-20100249181-A1 | HIV Protease Inhibiting Compounds | ABBOTT LABORATORIES (US) | 2010-09-30 | — | — | US | claimed |
| JP-2007516260-A | — | — | 2007-06-21 | — | — | JP | claimed |
| EP-1697344-A2 | HIV PROTEASE INHIBITING COMPOUNDS | ABBOTT LABORATORIES (US) | 2006-09-06 | — | — | EP | claimed |
| US-20050148623-A1 | Prevent reproduct of aids virus | ABBVIE INC. | 2005-07-07 | — | — | US | claimed |
| WO-2005058841-A2 | HIV PROTEASE INHIBITING COMPOUNDS | ABBOTT LABORATORIES (US) | 2005-06-30 | — | — | WO | claimed |
| US-20050131017-A1 | HIV protease inhibiting compounds | ABBOTT LABORATORIES | 2005-06-16 | — | — | US | claimed |
| US-20140194349-A1 | HIV Protease Inhibiting Compounds | ABBVIE INC. (US) | 2014-07-10 | — | — | US | disclosed |
| EP-2266971-A2 | Hiv protease inhibiting compounds | Abbott Laboratories (US) | 2010-12-29 | — | — | EP | disclosed |
| US-7834043-B2 | Prevent reproduct of aids virus | ABBOTT LABORATORIES (US) | 2010-11-16 | — | — | US | disclosed |
| US-20100249181-A1 | HIV Protease Inhibiting Compounds | ABBOTT LABORATORIES (US) | 2010-09-30 | — | — | US | disclosed |
| US-20050148623-A1 | Prevent reproduct of aids virus | ABBVIE INC. | 2005-07-07 | — | — | US | disclosed |
| US-20050131017-A1 | HIV protease inhibiting compounds | ABBOTT LABORATORIES | 2005-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050148623-A1 | Prevent reproduct of aids virus | SERPINB1, PRSS1, SERPINA3 | CYP3A4 481/4885CTSD 146/4885UGT1A1 1234/4885 |
| US-20050131017-A1 | HIV protease inhibiting compounds | SERPINB1, HPN, DNPEP | CYP3A4 764/4885CTSD 84/4885UGT1A1 2307/4885 |
| US-20100249181-A1 | HIV Protease Inhibiting Compounds | SERPINB1, HPN, DNPEP | CYP3A4 764/4885CTSD 84/4885UGT1A1 2307/4885 |
| US-20140194349-A1 | HIV Protease Inhibiting Compounds | SERPINB1, HPN, DNPEP | CYP3A4 764/4885CTSD 84/4885UGT1A1 2307/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.